SV Life Sciences — 2011 Investments
2 investments dated 2011 · listed companies and verified rows first · show all
CardioFocus develops Pulsed Field Ablation (PFA) technologies and systems for electrophysiologists to treat complex cardiac arrhythmias with precision and control.
BiotechHealthtechMedical DevicesMarlborough, US
Lauren Jennings(Executive Officer)Warren Clark(Executive Officer)Stephen Sagon(Executive Officer, Director)inAnjie Roldan(Executive Officer)inWarren R. Clark III(Executive Officer)Stephan S. Ogilvie(CEO)in
Co-investorsBioBritSaints CapitalSV Health InvestorsAccuitive Medical VenturesOxford Bioscience Partners
BiotechMt. Arlington, US
Paul Chaney(Executive Officer, Director)
BoardAbbie Celniker(Director)inDavid Guyer(Director)Bruce Peacock(Director)Kevin Starr(Director)inLutz Giebel(Director)
Co-investorsAstellas Venture Management LLCAgent CapitalSV Health InvestorsThird Rock Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.






